Unique formulation eases injections
With its slow-release pharmacokinetic profile, Sandostatin® LAR® can be administered once a month, reducing the need for frequent injections. An advanced microsphere formulation provides dependable, state-of-the-art delivery of octreotide, and a single injection provides smooth, consistent drug levels for the entire once-monthly treatment period, at all doses.
Enhanced needle size eases injections
A new, redesigned 1.1-mm-diameter 19-gauge needle size helps prevent clogging and facilitates easier administration of Sandostatin LAR.
Sandostatin LAR must be administered immediately after suspension.
To properly administer the injection, follow the steps below:
Eliminate air from syringe. Continually rock syringe gently to maintain uniform suspension.
Disinfect injection site with alcohol swab.
|Insert needle deep into right or left gluteus, and if no blood vessel has been penetrated, slowly inject suspension intramuscularly (IM) with steady pressure. If blood vessel is penetrated or if needle clogs, replace with new 1.1-mm diameter, 19-gauge needle. Sandostatin LAR must be given only by deep IM injection, never i.v.|
Make note of injection site on patient’s record and alternate site monthly.
More injection points:
This is an international site for Sandostatin® LAR® and is intended for Health Care Professionals outside the U.S. The information on the site is not country-specific, and may contain information that is outside the approved indications in the country in which you are located. Please contact your local Novartis representative for the latest information specific to your country.
Welcome to the SANDOSTATIN Product Website
SANDOSTATIN is approved for use in 92 countries around the world.
SANDOSTATIN Country-Level Websites
Below is a list of the countries that host a SANDOSTATIN website based on local label and in local language. They are intended for Health Care Professionals (HCPs) only. If you are a HCP from one of the countries listed below, click on your country link to be redirected to your country SANDOSTATIN website.
SANDOSTATIN International Website
This website is intended for Health Care Professionals (HCPs) outside the U.S. The information on this website is not country specific and may contain information that is outside the approved indication in the country in which you are located. Please contact your local representative for local prescribing information via www.novartisoncology.com/contactus.
IMPORTANT: The information on this website is based on the Sandostatin LAR Core Data Sheet